Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organizations (CMO). Contract research organization provides support to the pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.

Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2847

Market Dynamics

New strategies adopted by key players related to outsourcing drug discovery is expected to drive the growth of the global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a British drug manufacturing company collaborated with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines.

Furthermore, the extension of partnership activities is expected to propel global outsourced drug discovery market growth. For instance, in March 2017, Charles River Laboratories (CRL) extended its partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory program is related to preclinical drug development for the treatment of respiratory diseases and rare diseases.

The increasing number of drug discovery companies is expected to drive the growth of the global outsourced drug discovery market

The increasing number of new drug discovery companies is expected to drive the global outsourced drug discovery market growth. For instance, in November 2018, Schrodinger, LLC collaborated with Wuxi AppTec and launched a new drug discovery company, Faxian Therapeutics (Headquarter– New York, U.S.). Faxian Therapeutics will utilize the Schrodinger, LLC’s computational platform and WuXi’s drug design and synthesis services to improve health care needs.

Moreover, rising drug discovery services are expected to propel the growth of the global outsourced drug discovery market. For instance, in April 2019, Eurofins Discovery Services, a contract research organization, launched a new drug discovery service DiscoveryOne. The new approach is helpful for drug discovery research activities and preclinical developments. Hence, the launching of services related to drug discovery is expected to support the global outsourced drug discovery market growth.

Global Outsourced Drug Discovery Market - Competitive Landscape

Key players operating in the global outsourced drug discovery market are Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd., Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd.

Detailed Segmentation:

Global Outsourced Drug Discovery  Market, By Drug Type:
Small Molecule Drugs
Large Molecule Drugs
Global Outsourced Drug Discovery Market, By Services:
Preclinical Development
Target Validation and Functional Informatics
Target Identification and Screening
Lead Identification and Candidate Optimization
Others
Global Outsourced Drug Discovery Market, By Application
Oncology
Ophthalmology
Hematology
Immunomodulation
Anti-Infective Drugs
Dermatology
Pulmonology
Cardiology
Others
Global Outsourced Drug Discovery Market, By End User
Pharmaceutical and Biotechnological Companies
Contract Research Organization
Contract Manufacturing Organization
Global Outsourced Drug Discovery Market- Regional Analysis

North America outsourced drug discovery market is expected to account for the largest market share, owing to business expansion in this region. For instance, in January 2019, Lambda Therapeutic Research (Headquarter-India) acquired Novum Pharmaceutical Research Services, a U.S. CRO. With this acquisition, Lambda Therapeutic Research entered into the U.S. market.

Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/2847

Moreover, Europe is also projected to witness significant growth in the global outsourced drug discovery market, owing to increased merger and acquisition activities by key players in the region. For instance, in February 2019, Optimapharm, a clinical research organization (CRO) in Europe acquired Denothex, a CRO, for strengthening its presence in the European market particularly in France, Spain, Switzerland, and Italy. Denothex conducts all clinical trials in oncology across Europe and Israel.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]